Medicine & Healthcare

Surgeons restore some hand function to quadriplegic patient

Surgeons at Washington University School of Medicine in St. Louis, led by Susan E. Mackinnon, MD, have restored some hand function in a quadriplegic patient with a spinal cord injury at the C7 vertebra, the lowest bone in the neck. Instead of operating on the spine itself, the surgeons rerouted working nerves in the upper arms. These nerves still “talk” to the brain because they attach to the spine above the injury.MORE

Bonni to lead anatomy and neurobiology department

Azad Bonni, MD, PhD, currently professor of neurobiology at Harvard Medical School, will be the next head of the Department of Anatomy and Neurobiology at Washington University School of Medicine in St. Louis.MORE

Genetic test identifies eye cancer tumors likely to spread

Researchers at Washington University School of Medicine in St. Louis have developed a genetic test that can accurately predict whether the most common form of eye cancer will spread to other parts of the body, particularly the liver. The test successfully classified tumors more than 97 percent of the time.

Washington University receives $8 million to lead international childhood malnutrition effort

Jeffrey I. Gordon, MD, at Washington University School of Medicine in St. Louis will lead an international team of scientists to find new ways to diagnose, treat and prevent a critical global health problem: malnutrition in infants and children. The work is funded by an $8.3 million grant from the Bill & Melinda Gates Foundation. MORE

Volunteers needed for study to treat severe high blood pressure

Led by Jasvindar Singh, MD, doctors at Washington University School of Medicine in St. Louis are seeking volunteers for a clinical trial testing an investigational device in patients with severe high blood pressure that can’t be controlled with aggressive medical treatments.MORE

New technique could identify drugs that help fight broad range of viruses

Results of a new study from Washington University's Drug Discovery Center demonstrate the feasibility of a novel strategy in drug discovery: screening large numbers of existing drugs — often already approved for other uses — to see which ones activate genes that boost natural immunity.MORE

Warfarin no better than aspirin for most heart failure patients

Results of one of the largest studies of heart failure to date show that warfarin is no better than aspirin in reducing the combined risks of brain hemorrhage, stroke and death in most heart failure patients. Clinicians now have reassurance that aspirin is safe for heart failure patients with a normal heart rhythm, according to study co-author Douglas L. Mann, MD.

VIEW ALL MEDICINE & HEALTHCARE

media contacts

Joni Westerhouse

Assistant Vice Chancellor, Executive Director Medical News
(314) 286-0120
westerhousej@wustl.edu

Medicine & Healthcare

contacts for news media

Emergency Info